The Sirolimus market is anticipated to grow at a CAGR of 5.2% during the forecast period, reaching a value of US$ 337.54 million by 2029. The market growth is driven by several factors, including the increasing prevalence of various diseases such as cancer, organ transplant rejection, and certain autoimmune diseases, which require treatment with Sirolimus. Additionally, the growing...